ENANTA PHARMACEUTICALS INC's ticker is and the CUSIP is 29251M906. A total of 3 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $116,300 | -51.3% | 2,500 | -45.7% | 0.00% | – |
| Q3 2022 | $239,000 | +68.3% | 4,600 | +53.3% | 0.00% | – |
| Q2 2022 | $142,000 | -69.3% | 3,000 | -53.8% | 0.00% | – |
| Q1 2022 | $463,000 | +2986.7% | 6,500 | +3150.0% | 0.00% | – |
| Q4 2021 | $15,000 | -97.7% | 200 | -98.2% | 0.00% | -100.0% |
| Q3 2021 | $642,000 | +175.5% | 11,300 | +113.2% | 0.00% | – |
| Q2 2021 | $233,000 | +124.0% | 5,300 | +152.4% | 0.00% | – |
| Q1 2021 | $104,000 | +1980.0% | 2,100 | +2000.0% | 0.00% | – |
| Q2 2020 | $5,000 | -97.3% | 100 | -96.7% | 0.00% | -100.0% |
| Q4 2019 | $185,000 | +160.6% | 3,000 | +200.0% | 0.00% | 0.0% |
| Q4 2018 | $71,000 | -89.0% | 1,000 | -87.5% | 0.00% | -85.7% |
| Q1 2018 | $647,000 | -22.9% | 8,000 | -44.1% | 0.01% | +16.7% |
| Q4 2017 | $839,000 | +20875.0% | 14,300 | +14200.0% | 0.01% | – |
| Q1 2014 | $4,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 14 | $58,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |